Results for tag: "Cutaneous Malignancy"

Cutaneous malignancy is a type of cancer that affects the skin. It is a subset of hematology, which is the study of blood and blood-forming organs. Cutaneous malignancies can be divided into two main categories: melanoma and non-melanoma. Melanoma is the most serious type of skin cancer and is caused by the uncontrolled growth of pigment-producing cells. Non-melanoma skin cancers are more common and include basal cell carcinoma, squamous cell carcinoma, and other rarer types. Treatment for cutaneous malignancies typically involves surgery, radiation therapy, chemotherapy, and targeted therapy. Companies in the cutaneous malignancy market include Novartis, Merck, Bristol-Myers Squibb, Roche, and Eli Lilly. These companies are involved in the development and commercialization of drugs and treatments for cutaneous malignancies. Show Less Read more